Jul 17, 2023, 07:12
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
In a post by
Attached and available through the link please find the ePublished version for your reference: https://lnkd.in/ewdfhzE6
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 21, 2025, 06:28
Jan 21, 2025, 06:24
Jan 21, 2025, 05:44
Jan 21, 2025, 05:12
Jan 21, 2025, 04:58
Jan 21, 2025, 04:17